JAC Advance Access published online on November 18, 2002
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkf250
© 2002 by The British Society for Antimicrobial Chemotherapy
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Original Paper
1 Department of Microbiology
and Immunology, Showa University School of Medicine, 1-5-8 Hatanodai,
Shinagawa-ku, Tokyo 142-8555, Japan
* Corresponding author. E-mail: zqhu{at}med.showa-u.ac.jp.
Received 23 July 2001
; revised 27 December 2001
; accepted 9 September 2002
Additive, indifferent and antagonistic effects were
observed in combinations of epigallocatechin gallate (EGCg, a main
constituent of tea catechins) with12 non-
Additive, indifferent and antagonistic effects
in combinations of epigallocatechin gallate with 12 non-
-lactam
antibiotics against methicillin-resistant Staphylococcus aureus
2 Tokyo Food Techno Co., Ltd, Tokyo, Japan
-lactam
antibiotics against methicillin-resistant Staphylococcus aureus (MRSA). The combinations of EGCg with the
inhibitors of either protein or nucleic acid synthesis showed additive
or indifferent effects. These antibiotics included tetracycline,
minocycline, chloramphenicol, streptomycin, gentamicin, kanamycin,
erythromycin, rifampicin and ofloxacin. In contrast, EGCg showed
an antagonistic tendency against glycopeptide antibiotics (vancomycin,
teicoplanin and polymyxin B). The common property of these antibiotics
is the peptide backbone structure, suggesting a direct binding of
EGCg with the antibiotics. The above results indicate that tea catechins
may affect the activities of antibiotics both positively and negatively.![]()
CiteULike
Connotea
Del.icio.us What's this?